Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| Our recruiting pipeline from 2023 has been really strong, as you guys know, that compounds in a very predictable pattern for us |
| This marks the 12th consecutive quarter of same facility case growth and the third consecutive year this growth has been above our long-term target growth rate |
| Their working contributions allow us to deliver consistent and predictable results and drive sustained growth for all of our stakeholders |
| Starting with our 2023 results, we are extremely pleased with substantial progress we achieved related to our strategic initiatives and how these initiatives further catalyze our growth engine as we enter into 2024 |
| We have high confidence in these growth levers based on our historical experience and the compounding effect of activity that has already occurred in areas like physician recruiting and managed care contracting |
| Despite the macro headwinds faced by our industry over the past four years, including the inflationary impact on labor and supply costs and the global pandemic, the company has grown adjusted EBITDA at a compound annual growth rate of over 14% per annum and expanded margins by 210 basis points |
| When combined with our targeted increased acuity and contributions from recent acquisitions, net revenue grew 8% to $2.74 billion, inclusive of approximately $100 million of revenue divested early in the year, and adjusted EBITDA margins improved by 100 basis points, reflecting our cost discipline, acuity mix and enhanced rates |
| We are carrying the momentum of the strong finish to 2023 into 2024, with all of our growth engines operating effectively |
| Our 2023 growth was balanced with same-facility revenue growing more than 11%, representing case volume of approximately 4% and rate improvement of 7%, driven by acuity mix and enhanced managed care rates |
| Once again, our well-established and proven growth algorithm is firing on all cylinders and enables the company to confidently guide to double-digit adjusted EBITDA growth and margin expansion in 2024 and beyond |
| This growth in free cash flow is closely linked to the growth in our adjusted EBITDA, a trend we expect to continue to meaningfully enhance the company's liquidity position |
| For us, it's really a great offensive play, and we would share medtech's enthusiasm on that |
| As of this morning's call, our team has a strong pipeline of transactions under LOI and we continue to source new deals |
| Our guidance implies continued margin expansion, reflecting our ongoing and accretive progress in procurement and revenue cycle as well as the integration benefits from recent acquisitions and contributions from de novos we expect to open this year |
| I would also say that when we add robotics, to remind you, those are financed locally, so not a huge CapEx impact, and actually the ROI on those have been incredibly strong |
| And so, from our perspective, first and foremost, the joints are going to obviously bring a great economic value to us |
| Associated with this refinancing with support from our banking syndicate, we were also able to increase our revolving credit facility to $700 million, reflecting the continued strength of our business model and confidence in our growth algorithm |
| So, we were excited about the opportunity |
| It certainly reinforces our confidence in total joint growth |
| Margins benefited from revenue growth, effective cost management and contributions from our equity method investments, which we sometimes reference as minority partnerships |
| Our unique partnership model and our approach to enabling our physician partners' independence and strong community reputation allows us to naturally benefit from the continued side-of-care shift to our safe, high-quality and cost-effective facilities |
| So, feel very good from that perspective |
| And while we effectively managed it well, we've also been able to maintain a cost structure |
| Together, our partners win, our payers win, and most importantly, our patients get the best care possible for their surgical care needs |
| Our strong revenue growth was equally reflected in our adjusted EBITDA growth, which was $142.3 million in the fourth quarter, 17.8% higher than last year |
| Our organic growth initiatives translated into a strong full year 2023 top-line same-facility growth of just over 11% |
| First and foremost, core book will be expanding margins as well as the minority interest |
| As we've consistently demonstrated, the rate improvements we are seeing in our existing facilities are benefiting from the strategic focus on recruiting physicians specializing in higher acuity procedures, such as total joints |
| And just one more example is as things get added to the ASC list, the opportunity to create value for the system and to create value for Surgery Partners shareholders is tremendous |
| Most importantly, they also continue to serve our communities with the highest clinical care in a low-cost setting with the convenience and professionalism all our facilities are known to provide |
| Statement |
|---|
| But I must acknowledge, as you pointed out, that we missed how collections were going to come through, particularly in this fourth quarter revenue that was there and as a result of the cyber event that took place in the beginning of the year and just the complexity of doing paper-based billings and how that impacts our payers as we go through those |
| How much runway is left on that? And also G&A came in well below consensus |
| There is margin pressure, and the margin pressure is not as you would think |
| And the reason that's important to note is that the fourth quarter of this year, which was aligned with our expectations, had a very unique anomaly occur, which was that Christmas fell on a Monday |
| And we went from negative last year to $110 million |
| We attribute a large majority, predominant majority of that miss to, the $140 million that we had talked about before, to those two items |
| While this number is below our targeted goal of at least $200 million per year, we also closed an additional $60 million in transactions in early January that we had anticipated closing in the fourth quarter |
| That one did create some issues with us in terms of projecting cash flow, the reimbursement rates and when those -- the timing of when those reimbursements happened was more in '24 and little bit in '25 |
| One, as we saw all year and as we've been talking about quite frankly for the past two solid years, the business doesn't change rapidly |
| I've never been more optimistic regarding our future and the number of tailwinds impacting our business |
| And as our minority interest partnerships continue to mature, you'll see kind of continued upward pressure on there |
| Kevin Fischbeck And how much was that in the cash flow? Dave Doherty About half of the miss, maybe a little bit, somewhere around half of that miss versus the $140 million we've been talking about before |
| And it's a great question, Bill, because again, something could be somewhat confusing |
| As we're looking at the divestiture side, which the other point that gave us some pressure points last year, we're not looking at anything as significant as we did last year that will create that type of headwind, at least as we're talking at our portfolio level at this point |
| There are always puts and takes to our early guidance with risks we track and opportunities we pursue |
| But the year-over-year change that we see is remarkable kind of worth a pause as we look through this |
| There's no concern about the recovery of that |
| So, it creates a little bit of an odd anomaly in terms of comps of last year and the year before versus this year, but no concerns in terms of what we think is the basic algorithm and achieving that 2% to 3% plus |
| So, you're not actually going to see the pressure on margin that you were referring to |
| These headwinds have slowly abated throughout 2023 |
Please consider a small donation if you think this website provides you with relevant information